MolPort-002-051-370

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 24 USDMF, 7 CEP/COS, 2 JDMF, 5 EU WC, 7 KDMF, 37 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

12 API Suppliers

12 API Suppliers

FINISHED DOSAGE FORMULATIONS

231 FDF Dossiers, 102 FDA Orange Book, 44 Europe, 26 Canada, 24 Australia, 11 South Africa, 24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 10MG/5ML, SOLUTION;ORAL - 5MG/5ML, INJECTABLE;INTRATHECAL - 0.05MG/ML, INJECTABLE;INTRATHECAL - 0.5MG/ML, INJECTABLE;INTRATHECAL - 1MG/ML, INJECTABLE;INTRATHECAL - 2MG/ML

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 2 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 4 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 11 Kerry, 10 Microlex e.U, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 16 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 3 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 33 Direct Compression, 32 Disintegrants & Superdisintegrants, 17 Granulation, 16 Thickeners and Stabilizers, 16 Co-Processed Excipients, 13 Lubricants & Glidants, 10 Solubilizers, 8 Controlled & Modified Release, 8 Chewable & Orodispersible Aids, 5 Taste Masking, 4 Coating Systems & Additives, 4 Parenteral, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Film Formers & Plasticizers, 1 Rheology Modifiers